The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post–myocardial infarction heart failure: Trial rationale and study design

2018/04/03 by Amish N. Raval, Thomas D. Cook, Henricus J. Duckers +6 · 7 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Mesenchymal stem cell research #Pluripotent Stem Cells Research #Tissue Engineering and Regenerative Medicine

paper · doi:10.1016/j.ahj.2018.03.016

Cited by

• Function Follows Form - A Review of Cardiac Cell Therapy. [europepmc]
• Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies. [europepmc]
• Paracrine-mediated rejuvenation of aged mesenchymal stem cells is associated with downregulation of the autophagy-lysosomal pathway. [europepmc]
• The CardiAMP Cell Therapy for Heart Failure trial. [europepmc]
• Dare to dream? Cell-based therapies for heart failure after DREAM-HF: Review and roadmap for future clinical study. [europepmc]
• Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease. [europepmc]
• Efficacy and clinical outcomes of bone-marrow mononuclear cell therapy in chronic heart failure: a systemic review and meta-analysis. [europepmc]